Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2015

Oct 9, 2015

31949_dirs_2015-10-09_336c434b-2eff-42f8-9c93-af66b92414d5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-07

Reporting Person: Palti Yoram (Director, Chief Technology Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-07 Ordinary Shares C 130127 Acquired 130127 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-07 Series A Convertible Preferred Shares $ C 130127 Disposed Ordinary Shares (130127) Indirect

Footnotes

F1: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

F2: N/A.

F3: Pursuant to the issuer's memorandum & articles of association, all outstanding preferred shares of each series automatically converted into ordinary shares upon consummation of the issuer's initial public offering on October 7, 2015.